CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 14 enrolled
Drug / intervention
PD VitalOs cement® +2 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04443972
NCT04443972N/ACompleted
CompareCT.gov

Evaluation of Injectable Beta- Tricalcium Phosphate as an Occlusive Barrier Membrane in Treatment of Grade ii Furcation Involvement (Clinical and Radiographic Study)

Hams Hamed Abdelrahman·interventional·Posted Jun 23, 2020·Updated Jun 23, 2020

In Brief

A clinical study evaluating PD VitalOs cement®, Hydroxyapatite bone graft, and 1 other intervention for Furcation Defects. Completed, enrolled 14 participants across 1 site.

Detailed Summary

This study will be conducted to evaluate clinically and radiographically the use of PD VitalOs cement® bone graft in the treatment of class II furcation defects comparing with Hydroxyapatite bone graft and biodegradable collagen membrane in the treatment of class II furcation defects.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFurcation Defects
CountriesEgypt
CollaboratorsAlexandria University

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJun 23, 2020
Enrollment StartApr 12, 2018
Primary CompletionJul 10, 2019
Study CompletionFeb 4, 2020
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 6.0 years ago

Interventions

PD VitalOs cement®other

PD VitalOs cement®\* is a synthetic bone grafting cement designed for bone void filling and bone regeneration in dental surgery

Hydroxyapatite bone graftother

a bioceramic bone substitute, providing a scaffold for bone deposition

biodegardable collagen membraneother

provide efficacious barriers that were interposed between the flap and root surface.